Where is CymaBay headquartered?

CymaBay is located in Newark, CA.

Who invested in CymaBay?

CymaBay has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for CymaBay?

CymaBay closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

cymabay.com

CymaBay

CymaBay is a biopharmaceutical company that focuses on developing therapies for liver and chronic diseases.

Business Model:

Revenue: $19.2M

Employees: 51-200

Geographic Data

Address: 7575 Gateway Boulevard

City: Newark

State: CA

Zip: 94560

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$75M

Raised Total:

$146M

Social

Facebook

Twitter

Crunchbase

Metrics

9,496,388Website Global Rank

147Website Monthly Traffic

Twitter Followers

Description

CymaBay is a biopharmaceutical company that focuses on developing therapies for liver and chronic diseases.

Contact Phone:
+15102938800

Contact Email:

IPO Details

CymaBay went public on 7/18/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/18/2014

Ticker Symbol:
CBAY

Amount Raised:
$22M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2021	Post-IPO Debt	1	$100M	Abingworth Abingworth
11/2009	Equity		$5.6M	Bay City Capital venBio Alta Partners Versant Ventures
7/2009	Debt Financing		$27.7M
3/2008	Debt		$27.7M	Bay City Capital venBio Alta Partners Versant Ventures
12/2013	Debt Financing	2	$5M	Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC
7/2014	IPO		$22.8M
9/2013	Equity		$30.2M	Bay City Capital VenBio Alta Partners
8/2003	Series A	4	$27M	Charter Venture Group CDP Capital Technology Ventures Biotech Turnaround Fund (BTF) Bay City Capital Charter Venture Group CDP Capital Technology Ventures Biotech Turnaround Fund (BTF) Bay City Capital
12/2004	Series B	7	$44M	Alta Partners Versant Ventures Venrock Novo Holdings KBC Birchmere Ventures Bay City Capital Alta Partners
1/2023	Post-IPO Equity		$85M
11/2009	Series E		$0	Merlin Biomed Birchmere Ventures Alta Partners KBC Bay City Capital Next Chapter Holdings Versant Ventures Charter Life Sciences Novo Ventures Pictet Private Equity Investors S.A. VantagePoint Capital Partners Venrock Merlin Biomed Birchmere Ventures Alta Partners KBC Bay City Capital Next Chapter Holdings Versant Ventures Charter Life Sciences Novo Ventures Pictet Private Equity Investors S.A. VantagePoint Capital Partners Venrock
1/2000	Venture Round		$10M
1/2004	Venture Round	1	-	Omega Funds Omega Funds
10/2013	Venture Round		$26.8M
8/2006	Series C		$10M
4/2007	Series D	15	$32M	Versant Ventures Venrock VantagePoint Capital Partners T. Rowe Price Pictet Private Equity Investors S.A. Novo Ventures Merlin Biomed KBC Johnson &a; Johnson Development Corporation Deerfield Capital Management
8/2015	Post-IPO Debt		$325k
11/2021	Post-IPO Debt		$75M
11/2009	Series E	12	$8.6M	Merlin Biomed Birchmere Ventures Alta Partners KBC Bay City Capital Next Chapter Holdings Versant Ventures Merlin Biomed Birchmere Ventures Alta Partners KBC Bay City Capital Next Chapter Holdings Versant Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details